Evidence map›Paper›PMID 42507653›Full record

ArticlePloS one2026

Dual regulatory effects of medical bovine collagen sponge on macrophages in vitro.

Rui Wang, Yu Liu, Jingjing Chen, Zhu Meng, Weiye Ren, Wei Huang, Zhaoxu Wang, Qianqian Han

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rui WangDepartment of Medical Devices, National Institutes for Food and Drug Control, Beijing, China.ORCID https://orcid.org/0000-0002-6725-6153
Yu LiuDepartment of Medical Devices, National Institutes for Food and Drug Control, Beijing, China.
Jingjing ChenDepartment of Medical Devices, National Institutes for Food and Drug Control, Beijing, China.
Zhu MengDepartment of Medical Devices, National Institutes for Food and Drug Control, Beijing, China.
Weiye RenWuxi Biot Biology Technology Co., Ltd, Jiangsu Province, China.
Wei HuangDepartment of Emergency, Beijing Stomatological Hospital, Beijing, China.
Zhaoxu WangDepartment of Medical Devices, National Institutes for Food and Drug Control, Beijing, China.
Qianqian HanDepartment of Medical Devices, National Institutes for Food and Drug Control, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical bovine collagen sponges (MBCS) are extensively utilized in clinical settings for hemostasis and tissue augmentation owing to their superior biocompatibility, biodegradability and hemostatic properties. Nevertheless, their immunomodulatory influence on macrophage function remains largely unexplored. In this study, we systematically evaluated the effects of MBCS on RAW264.7 macrophages through comprehensive in vitro assays, including proliferation analysis, phagocytosis assessment, cytokine expression and angiogenesis evaluation. Our results demonstrate that MBCS significantly enhances macrophage proliferation and phagocytic capacity while potently stimulating VEGF secretion. Furthermore, MBCS-conditioned macrophage supernatants markedly promote endothelial tubule formation in vitro. Notably, MBCS moderately promotes inflammatory responses in resting macrophages, whereas pretreatment with MBCS effectively inhibits lipopolysaccharide (LPS)-induced pro-inflammatory reactions, as reflected by reduced production of TNF‑α, nitric oxide and CD86. These findings reveal the effects of MBCS on macrophages at the cellular level, providing experimental evidence and mechanistic support for its tissue-repairing functions.

Indexed as

CollagenMacrophagesAnimalsCattleCell ProliferationCytokinesLipopolysaccharidesMiceNitric OxidePhagocytosisRAW 264.7 CellsTumor Necrosis Factor-alphaVascular Endothelial Growth Factor ACollagenCytokinesLipopolysaccharidesNitric OxideTumor Necrosis Factor-alphaVascular Endothelial Growth Factor A

Identifiers

PMID42507653
PMCPMC13405066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.